Eli Lilly sheds light on confidential drug pricing, discloses charges for popular diabetes medicine Humalog

25 March 2019 - Eli Lilly says the “net price” for insulin fell to $135 a patient a month in 2018 ...

Read more →

Drug prices on TV? They may be coming.

23 March 2019 - The Trump administration is moving ahead with its proposal to require drug companies to disclose the ...

Read more →

Health Canada begins release of clinical data on drugs and devices

14 March 2019 - Health Canada launched two public databases on Wednesday as the first step in making clinical information ...

Read more →

CMS updates drug dashboards with prescription drug pricing and spending data

14 March 2019 - Dashboards further the agency’s efforts to increase price transparency throughout the healthcare system and create incentives ...

Read more →

Rx drug costs: list prices versus net prices and the importance of staying within the data

13 March 2019 - The authors of a recent Health Affairs article asked a meaningful question: Are new drugs or ...

Read more →

Why the Italian health minister is pushing for global transparency on drug pricing

12 March 2019 - Last month, the Italian government asked the World Health Assembly to adopt a resolution to require drug ...

Read more →

Italy proposes the WHO set international standards for drug pricing transparency

14 February 2019 - As more countries seek to control their health care spending, the Italian government is asking the ...

Read more →

Whether the TGA should publish that a prescription medicine is under evaluation

15 February 2019 - The TGA is seeking comments from interested parties on whether or not the TGA should in future ...

Read more →

OIA responses: exploring ways to publish them

14 February 2019 - To support New Zealand's commitment to open government, PHARMAC is exploring ways to publish more of ...

Read more →

Trump plan to force drug makers to advertise prices might work, but not if pharma gets its way

23 January 2019 - Trump administration proposal to require drug makers to advertise prices in television ads could dissuade consumers ...

Read more →

Trump's drug ad price transparency contains huge loophole, researchers identify

22 January 2019 - The Trump administration's proposal to require pharmaceutical companies to list drug prices in television ads would ...

Read more →

2019 April price disclosure cycle – indicative prices

18 January 2019 - Indicative 1 April 2019 prices resulting from the 2019 April cycle of price disclosure have now been ...

Read more →

Drug maker won't put price in TV ads, but patients can look it up

8 January 2019 - Eli Lilly will tout website in spots for biggest diabetes drug. ...

Read more →

Price disclosure 2019 April cycle outcomes summary

14 December 2018 - The summary of price disclosure price reductions for the 2019 April Cycle has now been published. ...

Read more →

Disclosing prescription-drug prices in advertisements — legal and public health issues

14 November 2018 - On October 15, 2018, the CMS proposed a rule requiring television advertisements for prescription drugs and ...

Read more →